---
title: "BIOCAUSE HEILEN PHARMA (301211.SZ) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301211.SZ/norm.md"
symbol: "301211.SZ"
name: "BIOCAUSE HEILEN PHARMA"
parent: "https://longbridge.com/en/quote/301211.SZ.md"
datetime: "2026-03-10T00:28:09.034Z"
locales:
  - [en](https://longbridge.com/en/quote/301211.SZ/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301211.SZ/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301211.SZ/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/301211.SZ/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301211.SZ/norm.md)


# BIOCAUSE HEILEN PHARMA (301211.SZ) — Financial Reports

## Income Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.0066 | 0.0158 | 0.0276 | 0.0412 | 0.0148 |
| ROE | 0.42% | 1.44% | 1.78% | 2.93% | 1.08% |
| Revenue | 84.13M | 120.32M | 114.45M | 111.87M | 92.13M |
| Net income | 2.39M | 8.22M | 10.33M | 16.89M | 6.17M |
| Operating income | -4.02M | -1.11M | 824703.00 | 4.26M | -8.32M |
| Gross margin | 19.89% | 19.42% | 22.18% | 24.23% | 15.96% |
| Net margin | 2.84% | 6.83% | 9.02% | 15.09% | 6.69% |
| Profit quality | -38.38% | -47.50% | 13.62% | 9.04% | -48.96% |

## Balance Sheet (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 2.40B | 2.39B | 2.47B | 2.49B | 2.44B |
| Leverage | 1.06 | 1.06 | 1.06 | 1.08 | 1.06 |
| BVPS | 5.41 | 5.40 | 5.56 | 5.53 | 5.50 |
| Turnover | 0.1781 | 0.1820 | 0.1684 | 0.1771 | 0.1842 |
| Cash & STI | 1.57B | 1.57B | 1.62B | 1.64B | 1.62B |
| Inv & Rec | 122.02M | 115.90M | 133.73M | 137.85M | 155.09M |
| LT assets | 538.35M | 528.25M | 530.66M | 527.75M | 474.80M |
| Net debt | -1.57B | -1.57B | -1.62B | -1.63B | -1.61B |

## Cash Flow Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 10.47M | 2.34M | 6.06M | 47.11M | 17.00M |
| Investing CF | -5.51M | 106.87M | -54.62M | -24.25M | -518.43M |
| Financing CF | 0.0000 | -72.82M | - | -1.63M | 0.0000 |
| Free CF | -34.46M | 32.90M | -52.53M | 40.44M | -20.79M |
| OCF coverage | 62.93% | 3.31% | 22.63% | 104.00% | 62.21% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -16.64M | 1.11M | -26.76M | -45.30M | -27.33M |

## Distribution Plan

**Dividend Yield**: 1.41

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.25CNY | 2025-05-23 | 2025-05-26 | 2025-05-26 |
| Cash Dividend: 
0.48CNY | 2024-05-24 | 2024-05-27 | 2024-05-27 |
| Cash Dividend: 
0.4CNY. 
Share conversation: 0.2 for 1 | 2023-05-30 | 2023-05-31 | 2023-05-31 |